The influence of age and sex on disease development in a novel animal model of cardiac cachexia

International Journal of Cardiology

Volumn 133, Issue 3, 2009, Pages 388-393

  Palus, Sandra ^a   Akashi, Yoshihiro ^a   von Haehling, Stephan ^b   Anker, Stefan D ^b   Springer, Jochen ^a  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Body composition; Cardiac cachexia; Gender; Heart failure

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CARDIAC CACHEXIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; WEIGHT REDUCTION; AGE; AGING; ANIMAL; CACHEXIA; COMPARATIVE STUDY; COMPLICATION; DISEASE MODEL; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; SEXUAL DEVELOPMENT; SPRAGUE DAWLEY RAT;

AGE FACTORS; AGING; ANIMALS; CACHEXIA; DISEASE MODELS, ANIMAL; FEMALE; HEART FAILURE; MALE; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; SEX FACTORS;

EID: 63149149360     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.01.060     Document Type: Article

References (24)

1. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 349 (1997) 1050-1053
2. von Haehling S., Lainscak M., Springer J., and Anker S.D. Cardiac cachexia: a systematic overview. Pharmacol Ther (2008) 10.1016/j.pharmthera.2008.09.009
3. Joppa M.A., Gogas K.R., Foster A.C., and Markison S. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides 28 (2007) 636-642
4. Argiles J.M., Figueras M., Ametller E., et al. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells. Muscle Nerve. 37 (2008) 190-195
5. Nagaya N., Uematsu M., Kojima M., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 104 (2001) 1430-1435
6. Akashi Y.J., Palus S., Datta R., et al. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int J Cardiol 22 (2008) 22
7. Springer J., von Haehling S., and Anker S.D. The need for a standardized definition for cachexia in chronic illness. Nat Clin Pract Endocrinol Metab. 2 (2006) 416-417
8. Evans W.J., Morley J.E., Argiles J., et al. Cachexia: a new definition. Clin Nutr 27 (2008) 793-799
9. Anker S.D., Clark A.L., Winkler R., et al. Statin use and survival in patients with chronic heart failure-results from two observational studies with 5200 patients. Int J Cardiol 112 (2006) 234-242
10. Kalantar-Zadeh K., Anker S.D., Horwich T.B., and Fonarow G.C. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol 101 (2008) 89E-103E
11. Witte K.K., Ford S.J., Preston T., Parker J.D., and Clark A.L. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Int J Cardiol 15 (2007) 15
12. Arutyunov G.P., Kostyukevich O.I., Serov R.A., Rylova N.V., and Bylova N.A. Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure. Int J Cardiol 125 (2008) 240-245
13. Siednienko J., Jankowska E.A., Banasiak W., Gorczyca W.A., and Ponikowski P. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure. Int J Cardiol 122 (2007) 111-116
14. Anker S.D., Volterrani M., Pflaum C.D., et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol. 38 (2001) 443-452
15. Thayu M., Shults J., Burnham J.M., Zemel B.S., Baldassano R.N., and Leonard M.B. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis. 13 (2007) 1121-1128
16. Davidson W., Ash S., Capra S., and Bauer J. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr. 23 (2004) 239-247
17. Morgello S., Mahboob R., Yakoushina T., Khan S., and Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med. 126 (2002) 182-190
18. Andreotti F., Conti E., Lanza G.A., and Crea F. Sex, survival bias, and mortality following acute myocardial infarction. Ital Heart J. 4 (2003) 508-510
19. Miric L., Miric D., Duplancic D., et al. Specific and gender differences between hospitalized and out of hospital mortality due to myocardial infarction. Coll Antropol. 32 (2008) 361-367
20. Guerra S., Leri A., Wang X., et al. Myocyte death in the failing human heart is gender dependent. Circ Res. 85 (1999) 856-866
21. Modena M.G., Molinari R., Muia Jr. N., Castelli A., Pala F., and Rossi R. Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women. Am J Hypertens. 12 (1999) 1000-1008
22. Carroll J.D., Carroll E.P., Feldman T., et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 86 (1992) 1099-1107
23. Zhai P., Eurell T.E., Cooke P.S., Lubahn D.B., and Gross D.R. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am J Physiol Heart Circ Physiol. 278 (2000) H1640-1647
24. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150